for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Axcella Health Inc

AXLA.O

Latest Trade

5.22USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

2.25

 - 

8.81

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest News

BRIEF-Axcella Announces Patent Issuances Covering AXA1665

* AXCELLA ANNOUNCES PATENT ISSUANCES COVERING AXA1665 Source text for Eikon: Further company coverage:

BRIEF-Axcella Health Says Entered Into Sales Agreement With SVB Leerink Relating To Shares Of Common Stock Offered By Prospectus

* AXCELLA HEALTH - ENTERED INTO SALES AGREEMENT WITH SVB LEERINK LLC RELATING TO SHARES OF COMMON STOCK OFFERED BY PROSPECTUS

BRIEF-Axcella Health Files For $125 Million Mixed Shelf

* AXCELLA HEALTH FILES FOR $125 MILLION MIXED SHELF - SEC FILING Source text: (https://bit.ly/37brM4P) Further company coverage:

BRIEF-Axcella Announces Pricing Of Public Offering Of Common Stock

* AXCELLA ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

BRIEF-Axcella Health Inc Files For Offering Of Up To 11.0 Mln Shares Of Common Stock

* AXCELLA HEALTH INC FILES FOR OFFERING OF UP TO 11.0 MILLION SHARES OF COMMON STOCK - SEC FILING Source: (https://bit.ly/3fFrU0l) Further company coverage:

BRIEF-Axcella Reports Q1 Loss Per Share Of $0.65

* AXCELLA REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Axcella Announces Positive Top-Line Data From AXA1125-003 Clinical Study Showing Multifactorial Activity In Adult Subjects With NAFLD

* AXCELLA ANNOUNCES POSITIVE TOP-LINE DATA FROM AXA1125-003 CLINICAL STUDY SHOWING MULTIFACTORIAL ACTIVITY IN ADULT SUBJECTS WITH NAFLD

BRIEF-Axcella Receives Fourth Patent Covering Emm Compositions

* AXCELLA RECEIVES FOURTH PATENT COVERING EMM COMPOSITIONS Source text for Eikon: Further company coverage:

BRIEF-Axcella Health Q4 Loss Per Share $0.68

* AXCELLA REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Axcella Announces Oral Presentation At 2020 International Conference On Frailty And Sarcopenia Research

* AXCELLA ANNOUNCES ORAL PRESENTATION AT 2020 INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH Source text for Eikon: Further company coverage:

BRIEF-Axcella Completes Enrollment Of Subjects In Axa1665-002 Study

* AXCELLA COMPLETES ENROLLMENT OF SUBJECTS IN AXA1665-002 STUDY

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up